Reported May 4, 2022 · Terminated
Losartan Potassium 50 mg Tablet, a) 30-count blister card (NDC# 70518-3282-1), b) 60-count blister card (NDC:…
RemedyRepack Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: RemedyRepack Inc. · 625 Kolter Dr Ste 4 · Indiana, PA · 15701-3571
Is this the product you have?
Losartan Potassium 50 mg Tableta) 30-count blister card (NDC# 70518-3282-1)
- b) 60-count blister card (NDC70518-3282-0), Rx Only
- MFG byLupin Pharma, Baltimore, MD 21202
- Lot codes and dates
Lot # B1467803-120621exp. date 06/30/2022 Lot # J0585793-121721exp. date 12/31/2022
- Amount recalled
- 433/30 count blister cards, 33/60 count blister cards
Where it was sold
Why it was recalled
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new RemedyRepack Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.